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Background: Recently, RBFOX1, a gene encoding an RNA binding protein, has
consistently been associated with aggressive and antisocial behavior. Several loci in
the gene have been nominally associated with aggression in genome-wide association
studies, the risk alleles being more frequent in the general population. We have hence
examined the association of four RBFOX1 single nucleotide polymorphisms, previously
found related to aggressive traits, with aggressiveness, personality, and alcohol use
disorder in birth cohort representative samples.
Methods: We used both birth cohorts of the Estonian Children Personality Behavior
and Health Study (ECPBHS; original n = 1,238). Aggressiveness was assessed using
the Buss–Perry Aggression Questionnaire and the Lifetime History of Aggressiveness
structured interview at age 25 (younger cohort) or 33 (older cohort). Big Five personality
at age 25 was measured with self-reports and the lifetime occurrence of alcohol
use disorder assessed with the MINI interview. RBFOX1 polymorphisms rs809682,
rs8062784, rs12921846, and rs6500744 were genotyped in all participants. Given the
restricted size of the sample, correction for multiple comparisons was not applied.
Results: Aggressiveness was not significantly associated with the RBFOX1
genotype. RBFOX1 rs8062784 was associated with neuroticism and rs809682
with extraversion. Two out of four analyzed RBFOX1 variants, rs8062784 and
rs12921846, were associated with the occurrence of alcohol use disorder.
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Conclusions: In the birth cohort representative sample of the ECPBHS, no association
of RBFOX1 with aggressiveness was found, but RBFOX1 variants affected basic
personality traits and the prevalence of alcohol use disorder. Future studies on
RBFOX1 should consider the moderating role of personality and alcohol use patterns
in aggressiveness.
Keywords: RBFOX1, A2BP1, aggressiveness, neuroticism, extraversion, alcohol use disorder, gender
INTRODUCTION
Globally, more than 1.3 million people worldwide die each
year owing to aggressive behavior and violence (either self-
directed, interpersonal, and collective), accounting for 2.5% of
mortality (1). Nevertheless, from the evolutionary perspective,
aggression can be described as adaptive. Aggression belongs
to the behavioral repertoire of most species. Humans are a
rather highly aggressive species compared with other animals.
This may be related to the high benefit-to-cost ratio for
intraspecific aggression (2). Aggression in mammals, including
humans, has a high heritability (3, 4). Struggle for resources
(e.g., territory, suitable mates, food) must have substantially
contributed to the shaping of aggression by favoring gene variants
that promote agonistic behavior. However, when humans express
their inherent aggressiveness in an unfitting context, this may
lead to social maladjustment and crime (5).
Variance in many genes has been associated with
aggressiveness, with very small effects of each in the large
population studies by GWAS (6, 7). Recently, a novel candidate
gene, RBFOX1, has been linked to aggressive behavior by
convergent evidence from GWAS, epigenetic analyses, and
neuroimaging genetics, gene expression, and animal models (8).
RBFOX1 (RNA binding protein, Fox-1 homolog 1; also known
as ataxin 2-binding protein 1, A2BP1, or hexaribonucleotide-
binding protein 1, HRNBP1) encodes for the Fox-1 protein and
regulates alternative splicing that controls gene expression and,
in turn, coordinates neuronal brain activity (9, 10).
RNA binding proteins (RBPs) are key components in RNA
metabolism (11) by influencing the structure and interactions
of the RNAs and playing critical roles in their biogenesis,
stability, function, transport, and cellular localization (12).
Each RBP interacts with RNA in a unique sequence- or
structure-specific manner. Alternative splicing is one of the
central mechanisms regulating eukaryotic gene expression (13).
RBPs coordinate elaborate networks of RNA–protein and
protein–protein interactions that control RNA metabolism.
Hence, alterations in their RNA-binding function could impact
many genes and pathways, leading to complex, multifaceted
phenotypes (11, 14). Mutations in RBPs cause and/or contribute
to many human neurodevelopmental and neurologic disorders
(11, 15, 16). Abnormalities in the Fox-1 encoding gene,
RBFOX1, are associated with neurodevelopmental disorders (17).
Variations in the RBFOX1 have been associated with anxiety (9),
attention deficit/hyperactivity disorder (18), schizophrenia (19,
20), autism spectrum disorders (17), intellectual disability with
epilepsy (21), and gray matter loss in Alzheimer’s disease patients
(22). Conclusively, potential effects of the RBFOX1 genotype
are multiple and likely variable by sample specifics owing to
environmental interactions.
Several variants of RBFOX1 have been associated with
aspects of aggressiveness in a number of GWASs (23). The
C allele of rs6500744, located within the first intron, was
associated with conduct disorder symptoms in the interaction
with mothers’ warmth (24). Another SNP (rs8062784) in intron
1 of RBFOX1 was associated with anger in a GWAS assessing
hostility (25), and a variant located in intron 3 of the gene
(rs12921846) was associated with conduct disorder in a sample
of ADHD trios (26). A meta-analysis of nine population-
based GWASs including around 19,000 children provided
evidence for the contribution of RBFOX1 to children’s aggressive
behavior (7). Four SNPs in the RBFOX1 gene (rs809682,
rs12922093, rs12373031, and rs10521042, all located in the intron
regions) showed suggestive associations. Of these, the rs809682
polymorphism was demonstrated to have the lowest association
p-value, with the major T allele conferring the risk. Statistically
significant association was found for rs809682 when comparing
aggressive prisoners to controls and non-aggressive prisoners
(23). It should be noticed though that the direction of the effect
was not as in the original study.
We selected the SNPs showing the lowest association p-value
from every single reported GWAS [rs6500744, rs8062784,
rs809682, and rs12921846; see (23)] and assessed their association
with aggressiveness and basic personality traits in a birth cohort
representative sample of young adults. Given that antisocial
behavior is the main predictor of alcohol (mis)use and the other




The analysis was carried out on the Estonian Children Personality
Behavior and Health Study (ECPBHS) sample, the original
Estonian sample of the European Youth Heart Study (1998/99)
that was subsequently incorporated into the longitudinal
ECPBHS. All the subjects are of European descent. The principles
of formation of the original sample and procedure of first data
collection have been described in detail elsewhere (28). In brief,
this is a representative birth cohort sample of the Tartu city
and county with a school as the sampling unit. All schools of
Tartu County, Estonia, that agreed to participate (54 of the total
of 56) were included into the sampling using the probability
proportional to the number of students of the respective age
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groups in the school, and 25 schools were selected. All children
from grades 3 (younger birth cohort) and 9 (older birth cohort)
were invited to participate. ECPBHS is population representative,
while 79.1% of subjects of the randomized regional sample
participated in the original sampling. Details on follow-ups
have been described elsewhere [e.g., (29)], and the number
of participants in the presented analyses is given below. The
study was approved by the Ethics Review Committee on Human
Research of the University of Tartu. Written informed consent




During the last data collection waves (at age 25 years in the
younger cohort in 2014/2015 and at age 33 in the older cohort in
2016/2017), aggressive behavior was self-reported using the Buss-
Perry Aggression Questionnaire (30). The 29-item self-report
Buss-Perry Aggression Questionnaire (31) assesses four aspects
of aggressive behavior: Physical aggression, Verbal aggression,
Anger, and Hostility. Participants (n = 436 in the younger
and n = 499 in the older cohort) rated each statement on
a 5-point Likert Scale (uncharacteristic = 1, characteristic =
5). During the same data collection waves, the Life History of
Aggression interview [LHA; (32)] was carried out by experienced
clinical psychologists in order to assess dimensions of aggression
(n = 427 in the younger and n = 495 in the older cohort).
Items were scored only for the history of actual behavior
(33). LHA has three subscales: Aggression (temper tantrums,
physical fighting, verbal fighting, assaults on other people,
and assaults on property); Consequences/Antisocial Behavior
(school disciplinary problems, problems with supervisors at
work, antisocial behavior not resulting in police involvement,
and antisocial behavior involving the police); and Self-Directed
Aggression (assaults on self and suicide attempts). Each item was
rated on a 5-point scale, ranging from 0 = “no events” to 5 =
“more events than can be counted.”
Personality
Personality traits of the five-factor model (34) were measured by
self-reports at age 25 (n = 856) with EE.PIP-NEO (35), which
is a semantically simplified 240-item version of the International
Personality Item Pool (IPIP), which emulates the NEO-PI-R.
Alcohol Use Disorders
Assessment of lifetime occurrence of alcohol use disorders was
based on DSM-IV and was carried out in both cohorts (n= 931)
at age 25 by experienced clinical psychologists using the Mini-
International Neuropsychiatric Interview [M.I.N.I.5.0.0; (36);
Estonian version; (37)].
Genotyping
Genomic DNA was extracted from whole blood samples using
Qiagen QIAamp R© DNA Blood Midi Kit. The quantitative
real-time polymerase chain reaction (qRT-PCR) for genotyping
the four SNP polymorphisms was performed using TaqMan
Pre-Designed SNP Genotyping Assays (Applied Biosystems;
Foster City, CA, United States) containing primers and
fluorescent probes. For rs809682, the Assay C___8926788_10
was utilized; for rs8062784, rs12921846, and rs6500744
polymorphisms, the Assays C__29081048_20, C__32104163_10,
and C___3008571_10 were used, respectively. Genotyping
reactions were performed in a total volume of 10ml with ∼25
ng of template DNA. QRT-PCR reaction components and final
concentrations were as follows: 1:5 5 x HOT FIREPol R© Probe
qPCR Mix Plus (ROX) (Solis BioDyne) and 1:20 80 × TaqMan
Primers Probe.







Reactions were performed on the Applied Biosystems ViiATM
7 Real-Time PCR System. The amplification procedure consisted
of an initial denaturation step at 95◦C for 12min and 40 cycles
of 95◦C for 15 s and 60◦C for 1min. Positive and negative
controls were added to each reaction plate. No inconsistencies
occurred. Genotyping was performed blind to all phenotypic
data. Allele frequencies agreed with the National Center for
Biotechnology Information database and published reports.
Genotype frequencies were in Hardy-Weinberg equilibrium and
are shown in Table 1.
Statistical Analysis
Birth cohorts were pooled for analysis. Categorical variable
(genotype) relations to continuous variables were explored with
analysis of variance (ANOVA) and presented as F-statistic, raw
p-value and eta-squared (η2) as a measure of effect size. Fisher’s
least significance difference method (LSD) was used in all post
hoc comparisons. Contrasts were calculated for significant model
effects. Chi-square tests were conducted to assess the distribution
of Alcohol Use Disorder by genotype, and by genotype and
gender, and presented as χ²-statistic and raw p-value. For
fitting of the path model, we used the AMOS package of
structural equation modeling (SEM) by the MCMC (Markov
chain Monte Carlo) method. Genotype was entered into the
SEM model as a dichotomous variable: A/A homozygotes vs. T-
allele carriers. All p-values are reported as two-tailed, and results
are considered significant at the conventional p < 0.05 level;
correction for multiple testing is not applied. Statistical analyses
were performed using IBM SPSS Statistics, Version 25.
RESULTS
The Selected RBFOX1 Polymorphisms and
Aggressive Behavior
Aggressiveness assessed either using the self-report Buss-Perry
Aggression Questionnaire (Table 2) or the Lifetime History of
Aggression interview (Table 3) was not associated with any of the
RBFOX1 polymorphisms. This was the case for total scores as well
as subscales. No genotype by gender effect was found either.
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TABLE 1 | RBFOX1 genotype frequencies in the ECPBHS sample.
SNP rs6500744 rs8062784 rs809682 rs12921846
genotypes CC/CT/TT AA/AT/TT TT/AT/AA AA/AT/TT
MAF# in the whole sample MAF(T) = 0.37 MAF(T) = 0.06 MAF(A) = 0.26 MAF(T) = 0.21
Older cohort (n = 653) 262/300/91 580/70/3 342/268/43 399/229/25
Males (n = 290) 117/136/37 261/27/2 148/127/15 177/102/11
Females (n = 3 63) 145/164/54 319/43/1 194/141/28 222/127/14
Younger cohort (n = 580) 227/272/81 513/66/1 324/219/37 369/180/31
Males (n = 277) 115/118/44 239/37/1 168/95/14 173/92/12
Females (n = 303) 112/154/37 274/29/0 156/124/23 196/88/19
#MAF, minor allele frequency.
Personality and RBFOX1 Genotype
Neuroticism was associated with the RBFOX1 rs8062784, being
lower in homozygotes for the aggressiveness risk allele A
(Table 4). RBFOX1 rs809682 was associated with extraversion,
while the homozygotes for the risk allele T having higher scores.
No other polymorphism was statistically significantly associated
with neuroticism or extraversion.
RBFOX1 Polymorphisms and the
Occurrence of Alcohol Use Disorder
Alcohol use is a most salient mediator to aggressiveness, so the
association of RBFOX1 polymorphisms with lifetime prevalence
of alcohol use disorder by age 25 was examined. The overall
genotype effect (χ² = 4.14; p = 0.042) was revealed for RBFOX1
rs8062784 (Figure 1): This was largely based on male subjects
carrying the less frequent low aggressiveness allele T who had
almost twice higher risk of alcohol abuse. While analyzing males
and females separately, we found that rs12921846 (Figure 2) was
associated with alcohol use disorder in females (χ² = 4.22; p
= 0.045). Female RBFOX1 rs12921846 homozygotes for the less
frequent T-allele, also has been related to lower aggressiveness,
had higher alcohol abuse risk.
Alcohol Use Disorder, Sociodemographic
Factors, Personality, and the RBFOX1
rs8062784 Genotype
Next we examined the association of several factors potentially
related to alcohol use disorder at age 25, which is the last
observation for both cohorts. AUD was more prevalent in males:
10% of women and 38% of men had experienced AUD by age 25
(χ² = 102.8; df = 1; p < 0.001). In these birth cohorts, lifetime
alcohol use disorder was not associated with income in either
male or female subjects (data not shown), probably owing to
early age. At age 25, 58% of the participants were living with
a spouse, but there was no difference in lifetime occurrence
of AUD between subjects who lived with their spouse (21%)
compared with subjects who did not (25%). However, the lifetime
prevalence of AUD was higher (15%; n= 29) in females who did
not live with a spouse compared with those who did (8%; χ² =
6.3; df = 1; p = 0.01). There was a higher prevalence of AUD
among subjects with lower education level at age 25 (32 vs. 17%;
χ² = 28.99; df = 1; p < 0.001; males, 48 vs. 30%; χ² = 15.35; df
= 1; p < 0.001; females, 14 vs. 9%; χ² = 3.85; df = 1; p = 0.050);
but RBFOX1 genotype was not associated with education (data
not shown).
No interaction between the gender factor and lifetime alcohol
use disorder was found for the Big Five personality traits
(Table 5), but participants with AUD had significantly higher
neuroticism [F(1, 781) = 30.01; p < 0.001; η² = 0.037], lower
agreeableness [F(1, 774) = 9.39; p = 0.002; η² = 0.012], and
lower conscientiousness [F(1, 779) = 18.15; p < 0.001; η² =
0.023]. Because the RBFOX1 rs8062784 genotype and occurrence
of alcohol use disorder were both associated with neuroticism,
we examined whether or not the association of the RBFOX1
genotype could be mediated by this personality trait. According
to a Bayesian model by the Markov chain Monte Carlo method,
the RBFOX1 rs8062784 direct effect on AUD was not significant
(regression weight 0.19; Bayes’ credible interval −0.069. . . 0.455;
probability 95%), the RBFOX1 rs8062784 effect on Neuroticism
was 7.69 (Bayes’ credible interval 1.84. . . 13.64; probability 95%),
and the neuroticism effect on AUD was 0.006 (0.0002. . . 0.009),
suggestive of the neuroticism mediated association of RBFOX1
with alcohol use disorder (Figure 3).
DISCUSSION
Four polymorphisms of the RBFOX1 gene, previously linked
to aspects of aggressive behavior, were in the ECPBHS
sample not associated with aggressiveness in young adulthood,
neither by self-report nor interview measurement. Genome-
wide association studies indicate a very small effect of each
gene on aggressiveness in human population, so given the
size of the sample, this may not be surprising. Nevertheless,
when performing subgroup analyses by ethnicity, age of
participants, sample characteristics, and outcome measures,
significant associations emerge (6). Several variants in a number
of candidate genes have been found strongly associated with
aggression measures in the ECPBHS sample [see (29, 33)
and references therein]. It should hence be concluded that
in this specific population of which the ECPBHS sample is
highly representative, other genes than RBFOX1 play a role
in aggressiveness. Thus, other genetic variants than the ones
inspected play a role in aggressiveness in this sample, although we
cannot exclude other variants in RBFOX1 not investigated here.
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TABLE 2 | RBFOX1 genotypes and the Buss-Perry Aggression Questionnaire at age 25.
Genotype main effects Genotype by gender effects
Main statistics Scores Main statistics Scores for males Scores for females
rs809682
Physical aggression F (2, 923) = 0.07,
p = 0.937,
η² < 0.001
AA = 16.53 ± 0.77
AT = 16.53 ± 0.31
TT = 16.67 ± 0.27
F (2, 920) = 0.94,
p = 0.391,
η² = 0.002
AA = 19.52 ± 1.27
AT = 19.04 ± 0.50
TT = 18.46 ± 0.41
AA = 14.77 ± 0.88
AT = 14.83 ± 0.37
TT = 15.20 ± 0.33
Verbal Aggression F (2, 923) = 1.23,
p = 0.292,
η² = 0.003
AA = 14.07 ± 0.49
AT = 13.61 ± 0.20
TT = 13.34 ± 0.18
F (2, 920) = 0.01,
p = 0.986,
η² < 0.001
AA = 14.87 ± 0.78
AT = 14.38 ± 0.31
TT = 14.10 ± 0.25
AA = 13.60 ± 0.63
AT = 13.09 ± 0.26
TT = 12.72 ± 0.24
Anger F (2, 923) = 0.58,
p = 0.558,
η² = 0.001
AA = 15.23 ± 0.66
AT = 15.75 ± 0.27
TT = 15.40 ± 0.23
F (2, 920) = 0.48,
p = 0.619,
η² = 0.001
AA = 15.35 ± 1.07
AT = 15.19 ± 0.42
TT = 14.74 ± 0.34
AA = 15.17 ± 0.83
AT = 16.17 ± 0.35
TT = 15.95 ± 0.32
Hostility F (2, 923) = 0.98,
p = 0.375,
η² = 0.002
AA = 18.63 ± 0.71
AT = 17.67 ± 0.29
TT = 17.58 ± 0.25
F (2, 920) = 0.71,
p = 0.494,
η² = 0.002
AA = 19.83 ± 1.08
AT = 17.72 ± 0.42
TT = 17.88 ± 0.35
AA = 17.92 ± 0.93
AT = 17.63 ± 0.39
TT = 17.33 ± 0.35
BP total F (2, 923) = 0.30,
p = 0.742,
η² = 0.001
AA = 64.46 ± 2.04
AT = 63.55 ± 0.83
TT = 62.99 ± 0.72
F (2, 920) = 0.44,
p = 0.644,
η² = 0.001
AA = 69.57 ± 3.31
AT = 66.33 ± 1.30
TT = 65.18 ± 1.07
AA = 61.45 ± 2.54
AT = 61.67 ± 1.07
TT = 61.19 ± 0.97
rs8062784
Physical aggression F (2, 924) = 0.22,
p = 0.642,
η² < 0.001
AA = 16.57 ± 0.21
T-all = 16.86 ± 0.59
F (2, 922) = 0.04,
p = 0.852,
η² < 0.001
AA = 18.74 ± 0.34
T-all = 18.76 ± 0.87
AA = 14.99 ± 0.25
T-all = 15.23 ± 0.72
Verbal aggression F (2, 924) = 0.05,
p = 0.822,
η² < 0.001
AA = 13.49 ± 0.14
T-all = 13.58 ± 0.38
F (2, 922) = 0.37,
p = 0.546,
η² < 0.001
AA = 14.21 ± 0.20
T-all = 14.51 ± 0.54
AA = 12.96 ± 0.18
T-all = 12.77 ± 0.52
Anger F (2, 924) = 0.13,
p = 0.721,
η² < 0.001
AA = 15.51 ± 0.18
T-all = 15.70 ± 0.50
F (2, 922) = 0.81,
p = 0.370,
η² = 0.001
AA = 14.98 ± 0.28
T-all = 14.69 ± 0.73
AA = 15.89 ± 0.24
T-all = 16.56 ± 0.69
Hostility F (2, 924) = 0.21,
p = 0.646,
η² < 0.001
AA = 17.65 ± 0.19
T-all = 17.92 ± 0.54
F (2, 922) = 3.62,
p = 0.057,
η² = 0.004
AA = 18.05 ± 0.28
T-all = 17.11 ± 0.74
AA = 17.36 ± 0.27
T-all = 18.61 ± 0.77
BP total F (2, 924) = 0.26,
p = 0.614,
η² < 0.001
AA = 63.22 ± 0.56
T-all = 64.05 ± 1.56
F (2, 922) = 0.77,
p = 0.380,
η² = 0.001
AA = 65.99 ± 0.86
T-all = 65.08 ± 2.27
AA = 61.20 ± 0.73
T-all = 63.18 ± 2.10
rs12921846
Physical aggression F (2, 923) = 0.34,
p = 0.715,
η² = 0.001
AA = 16.56 ± 0.25
AT = 16.74 ± 0.34
TT = 15.92 ± 0.97
F (2, 920) = 0.34,
p = 0.712,
η² = 0.001
AA = 18.70 ± 0.39
AT = 18.77 ± 0.52
TT = 19.29 ± 1.63
AA = 15.0 ± 0.30
AT = 15.19 ± 0.41
TT = 14.04 ± 1.09
Verbal aggression F (2, 923) = 0.75,
p = 0.474,
η² = 0.002
AA = 13.41 ± 0.16
AT = 13.57 ± 0.22
TT = 14.15 ± 0.62
F (2, 920) = 0.78,
p = 0.459,
η² = 0.002
AA = 14.31 ± 0.24
AT = 14.07 ± 0.32
TT = 15.0 ± 1.0
AA = 12.74 ± 0.22
AT = 13.19 ± 0.29
TT = 13.68 ± 0.78
Anger F (2, 923) = 0.37,
p = 0.688,
η² = 0.001
AA = 15.42 ± 0.22
AT = 15.68 ± 0.29
TT = 15.92 ± 0.83
F (2, 920) = 0.82,
p = 0.440,
η² = 0.002
AA = 14.72 ± 0.33
AT = 15.18 ± 0.44
TT = 16.57 ± 1.37
AA = 15.94 ± 0.29
AT = 16.07 ± 0.39
TT = 15.56 ± 1.04
Hostility F (2, 923) = 1.14,
p = 0.322,
η² = 0.002
AA = 17.47 ± 0.23
AT = 18.04 ± 0.31
TT = 18.00 ± 0.89
F (2, 920) = 0.22,
p = 0.800,
η² < 0.001
AA = 17.83 ± 0.33
AT = 18.10 ± 0.45
TT = 18.14 ± 1.39
AA = 17.20 ± 0.32
AT = 17.99 ± 0.43
TT = 17.92 ± 1.16
BP total F (2, 923) = 0.56,
p = 0.571,
η² = 0.001
AA = 62.88 ± 0.67
AT = 64.03 ± 0.90
TT = 64.0 ± 2.57
F (2, 920) = 0.30,
p = 0.739,
η² = 0.001
AA = 65.56 ± 1.02
AT = 66.12 ± 1.37
TT = 69.0 ± 4.25
AA = 60.88 ± 0.88
AT = 62.43 ± 1.19
TT = 61.20 ± 3.17
rs6500744
Physical aggression F (2, 923) = 0.77,
p = 0.462,
η² = 0.002
CC = 16.37 ± 0.31
CT = 16.87 ± 0.29
TT = 16.42 ± 0.54
F (2, 920) = 0.18,
p = 0.837,
η² < 0.001
CC = 18.60 ± 0.48
CT = 19.03 ± 0.46
TT = 18.24 ± 0.82
CC = 14.65 ± 0.38
CT = 15.34 ± 0.35
TT = 14.99 ± 0.65
Verbal aggression F (2, 923) = 0.61,
p = 0.543,
η² = 0.001
CC = 13.63 ± 0.20
CT = 13.47 ± 0.19
TT = 13.19 ± 0.35
F (2, 920) = 1.07,
p = 0.342,
η² = 0.002
CC = 14.33 ± 0.29
CT = 14.42 ± 0.28
TT = 13.47 ± 0.50
CC = 13.10 ± 0.27
CT = 12.79 ± 0.25
TT = 12.97 ± 0.47
Anger F (2, 923) = 2.27,
p = 0.104,
η² = 0.005
CC = 15.59 ± 0.27
CT = 15.74 ± 0.25
TT = 14.63 ± 0.46
F (2, 920) = 0.17,
p = 0.843,
η² < 0.001
CC = 14.89 ± 0.40
CT = 15.26 ± 0.38
TT = 14.09 ± 0.69
CC = 16.13 ± 0.36
CT = 16.08 ± 0.33
TT = 15.05 ± 0.62
Hostility F (2, 923) = 2.09,
p = 0.124,
η² = 0.005
CC = 17.78 ± 0.29
CT = 17.87 ± 0.27
TT = 16.75 ± 0.50
F (2, 920) = 0.31,
p = 0.737,
η² = 0.001
CC = 17.92 ± 0.41
CT = 18.12 ± 0.39
TT = 17.39 ± 0.70
CC = 17.67 ± 0.40
CT = 17.70 ± 0.37
TT = 16.24 ± 0.69
(Continued)
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TABLE 2 | Continued
Genotype main effects Genotype by gender effects
Main statistics Scores Main statistics Scores for males Scores for females
BP total F (2, 923) = 1.66,
p = 0.191,
η² = 0.004
CC = 63.37 ± 0.83
CT = 63.95 ± 0.78
TT = 60.99 ± 1.43
F (2, 920) = 0.08,
p = 0.927,
η² < 0.001
CC = 65.74 ± 1.24
CT = 66.84 ± 1.19
TT = 63.20 ± 2.14
CC = 61.55 ± 1.09
CT = 61.90 ± 1.01
TT = 59.26 ± 1.90
TABLE 3 | RBFOX1 genotypes and the life history of aggression interview at age 25.
Genotype main effects Genotype by gender effects
Main statistics Scores Main statistics Scores for males Scores for females
rs809682
Aggression F (2, 919) = 0.14,
p = 0.872,
η² < 0.001
AA = 6.27 ± 0.55
AT = 5.97 ± 0.22
TT = 6.0 ± 0.20
F (2, 916) = 0.79,
p = 0.453,
η² = 0.002
AA = 7.23 ± 0.98
AT = 7.34 ± 0.37
TT = 6.90 ± 0.31
AA = 5.75 ± 0.62
AT = 4.99 ± 0.26
TT = 5.24 ± 0.24
Antisocial behavior F (2, 919) = 1.43,
p = 0.240,
η² = 0.003
AA = 1.40 ± 0.36
AT = 2.04 ± 0.15
TT = 1.88 ± 0.13
F (2, 916) = 1.67,
p = 0.188,
η² = 0.004
AA = 2.86 ± 0.73
AT = 3.89 ± 0.27
TT = 3.31 ± 0.23
AA = 0.60 ± 0.21
AT = 0.73 ± 0.09
TT = 0.69 ± 0.08
LHA totala F (2, 919) = 0.18,
p = 0.838,
η² < 0.001
AT = 7.84 ± 0.82
AT = 8.28 ± 0.33
TT = 8.07 ± 0.29
F (2, 916) = 0.86,
p = 0.426,
η² = 0.002
AA = 10.50 ± 1.58
AT = 11.33 ± 0.60
TT = 10.34 ± 0.50
AA = 6.38 ± 0.75
AT = 6.11 ± 0.32
TT = 6.19 ± 0.29
rs8062784
Aggression F (1, 920) = 1.19,
p = 0.276,
η² = 0.001
AA = 5.95 ± 0.15
T-all = 6.43 ± 0.42
F (2, 918) = 0.20,
p = 0.654,
η² < 0.001
AA = 7.02 ± 0.25
T-all = 7.61 ± 0.64
AA = 5.16 ± 0.18
T-all = 5.36 ± 0.52
Antisocial behavior F (1, 920) = 0.32,
p = 0.574,
η² < 0.001
AA = 1.89 ± 0.10
T-all = 2.06 ± 0.27
F (2, 918) = 0.60,
p = 0.439,
η² = 0.001
AA = 3.48 ± 0.18
T-all = 3.71 ± 0.48
AA = 0.72 ± 0.06
T-all = 0.55 ± 0.18
LHA total F (1, 920) = 0.86,
p = 0.353,
η² = 0.001
AA = 8.07 ± 0.23
T-all = 8.68 ± 0.62
F (2, 918) = 0.77,
p = 0.382,
η² = 0.001
AA = 10.61 ± 0.40
T-all = 11.57 ± 1.04
AA = 6.18 ± 0.22
T-all = 6.05 ± 0.63
rs12921846
Aggression F (2, 919) = 1.39,
p = 0.249,
η² = 0.003
AA = 5.82 ± 0.18
AT = 6.27 ± 0.24
TT = 6.53 ± 0.68
F (2, 916) = 0.14,
p = 0.870,
η² < 0.001
AA = 6.89 ± 0.29
AT = 7.41 ± 0.39
TT = 7.43 ± 1.23
AA = 5.03 ± 0.22
AT = 5.33 ± 0.30
TT = 6.04 ± 0.76
Antisocial Behavior F (2, 919) = 1.08,
p = 0.341,
η² = 0.002
AA = 1.82 ± 0.12
AT = 2.10 ± 0.16
TT = 1.80 ± 0.45
F (2, 916) = 1.55,
p = 0.214,
η² = 0.003
AA = 3.30 ± 0.22
AT = 3.86 ± 0.29
TT = 3.64 ± 0.91
AA = 0.71 ± 0.07
AT = 0.66 ± 0.10
TT = 0.81 ± 0.26
LHA total F (2, 919) = 1.41,
p = 0.246,
η² = 0.003
AA = 7.86 ± 0.27
AT = 8.57 ± 0.36
TT = 8.73 ± 1.02
F (2, 916) = 0.65,
p = 0.525,
η² = 0.001
AA = 10.31 ± 0.47
AT = 11.42 ± 0.62
TT = 11.14 ± 1.98
AA = 6.03 ± 0.26
AT = 6.24 ± 0.36
TT = 7.42 ± 0.93
rs6500744
Aggression F (2, 919) = 1.89,
p = 0.161,
η² = 0.004
CC = 5.94 ± 0.22
CT = 6.23 ± 0.21
TT = 5.41 ± 0.39
F (2, 916) = 0.75,
p = 0.474,
η² = 0.002
CC = 7.0 ± 0.36
CT = 7.51 ± 0.34
TT = 6.04 ± 0.62
CC = 5.11 ± 0.27
CT = 5.31 ± 0.25
TT = 4.90 ± 0.47
Antisocial behavior F (2, 919) = 0.22,
p = 0.801,
η² < 0.001
CC = 1.98 ± 0.15
CT = 1.88 ± 0.14
TT = 1.82 ± 0.25
F (2, 916) = 1.22,
p = 0.294,
η² = 0.003
CC = 3.52 ± 0.27
CT = 3.64 ± 0.26
TT = 3.07 ± 0.46
CC = 0.78 ± 0.09
CT = 0.60 ± 0.09
TT = 0.81 ± 0.16
LHA total F (2, 919) = 0.92,
p = 0.400,
η² = 0.002
CC = 8.18 ± 0.33
CT = 8.31 ± 0.31
TT = 7.42 ± 0.58
F (2, 916) = 1.18,
p = 0.308,
η² = 0.003
CC = 10.67 ± 0.57
CT = 11.26 ± 0.55
TT = 9.20 ± 1.0
CC = 6.23 ± 0.33
CT = 6.17 ± 0.30
TT = 5.99 ± 0.58
aThe total score of LHA is greater than subscales aggression and antisocial behavior together because it also contains self-directed aggressiveness. The latter scale is strongly skewed
toward non-occurrence of the behavior and did not reveal any significant genotype effect by non-parametric tests.
Neuroimaging genetic studies support the notion that the
RBFOX1 gene contributes to brain function and structure.
The expression levels of RBFOX1 in the brain are highest
in the anterior cingulate cortex that regulates emotions and
social behavior (38–41). The thickness of the ACC has been
associated with aggressiveness (41, 42), and in individuals prone
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Neuroticism F (2, 853) = 0.57,
p = 0.565,
η² = 0.001
AA = 73.5 ± 3.5
AT = 75.1 ± 1.4
TT = 73.3 ± 1.3
Extraversion F(2, 853) = 5.0,
p = 0.007,
η² = 0.012
AA = 105.6 ± 3.1
AT = 113.8 ± 1.3
TT = 115.7 ± 1.1
rs8062784
Neuroticism F(1, 854) = 7.20,
p = 0.007,
η² = 0.008
AA = 73.1 ± 1.0
T-all = 81.0 ± 2.8
Extraversion F (1, 854) = 1.98,
p = 0.160,
η² = 0.002
AA = 114.6 ± 0.8
T-all = 111.0 ± 2.5
Bold denotes statistically significant difference between groups.
to aggression, its activity in response to provocation is attenuated
(43). Furthermore, higher activity of ACC has been found in
aggressive adolescents with disruptive behavior disorders (44).
Yet anterior cingulate is involved in the whole complexity
of emotion regulation, and the meaning of any alteration at
the molecular level likely depends on the overall state of the
whole complex [e.g., (45)]. Because previous studies that have
implicated these specific variants of RBFOX1 were either on
selected groups of participants or relied on specific measures
of phenotype, we took the approach to study the association of
RBFOX1 with basic personality traits that could provide insight
into which factors play a role in the potential effect of RBFOX1.
Two of the polymorphisms were nominally associated with such
basic personality traits as neuroticism and extraversion.
Neuroticism was lower with two A-alleles of RBFOX1
rs8062784. Previously, this allele was associated with anger in a
GWAS that was targeted at hostility (25). Anger or hostility is
indeed a component of neuroticism in the five-factor model. For
this reason, we separately analyzed the six facets of neuroticism
and found four of them, including anger/hostility significantly
associated with the genotype (data not shown). Interestingly,
the weakest of the subscale associations was with impulsivity,
often a facilitative factor in aggressive behavior. While this
association of genotype and neuroticism could well-be a mere
chance finding, its direction also supports the hypothesis that
low neuroticism in the risk genotype in the present sample is
a mechanism preventing overt aggressiveness: In population-
derived samples, aggressive subjects appear to have higher
neuroticism (46–48).
RBFOX1 rs809682 was associated with extraversion:
Homozygotes for the T-allele had higher scores. The meta-
analysis of Pappa et al. (7) of nine population-based GWASs
of 19,000 children suggested the major T allele to carry the
aggression risk. Aggressiveness rating in these studies was based
on maternal scores, and this may differ from self-assessment
and interviews; moreover, levels of continuity of aggression
from childhood to early adulthood have been found to be only
FIGURE 1 | Association of RBFOX1 rs8062784 with alcohol use disorder in
males. Males, χ² = 7.01; p = 0.008 (n = 411); females, χ² = 0.45; p = 0.509
(n = 520). Lifetime diagnosis is based on MINI interview at age 25. AUD in 158
males out of 413 and 54 females out of 523 (in total, 212 out of 936).
FIGURE 2 | Association of RBFOX1 rs12921846 with alcohol use disorder in
females. Males, χ² = 0.41; p = 0.815 (n = 411); females, χ² = 6.22; p =
0.045 (n = 520). Lifetime diagnosis is based on MINI interview at age 25. AUD
in 158 males out of 413 and 54 females out of 523 (in total, 212 out of 936).
moderate (49). Furthermore, in a study of adult aggressive
prisoners, a significant association was found for rs809682;
however, the direction of the effect was opposite as in another
(7) study, this time with the minor A allele linked to aggression
(8), although the sample size was very limited. These conflicting
results may also find an explanation in the dual potential of
extraversion to moderate aggressiveness. Extraversion is the
tendency toward interaction with others, assertiveness, liveliness,
and action-orientation (50, 51). While aspects of extraversion
are defined as deriving from positive emotionality, another
central part of extraversion is assertiveness. Frost (52) made
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TABLE 5 | Personality traits at age 25 by gender and lifetime alcohol use disorder (AUD).
Females, no AUD Females with AUD Males, no AUD Males with AUD
Neuroticism 75.3 ± 1.3 92.1 ± 4.1 66.1 ± 1.6 76.1 ± 2.3
Extraversion 115.3 ± 1.2 118.1 ± 2.8 111.5 ± 1.6 115.7 ± 2.0
Openness 126.8 ± 1.0 127.9 ± 2.4 117.0 ± 1.3 115.7 ± 1.7
Agreeableness 129.5 ± 0.9 121.2 ± 2.6 118.3 ± 1.3 116.3 ± 1.6
Conscientiousness 130.4 ± 1.1 119.0 ± 3.4 124.8 ± 1.5 119.2 ± 1.7
FIGURE 3 | Mediation by neuroticism of the association of RBFOX1
rs8062784 and alcohol use disorder. Regression weights with credible
intervals (95%) are shown.
the early notion that extraverts tend to be more assertive and
lacking in submissiveness and self-criticism. Assertiveness
and verbal aggression have been demonstrated to correlate
positively (53), and extraversion has recently been shown to be
positively associated with physical aggression (54). Indeed, in our
exploratory analysis of the facets of extraversion, the RBFOX1
rs809682 T/T homozygocity was related rather to assertiveness,
activity, gregariousness, and positive emotions facets but less
to friendliness and excitement seeking (data not shown). Thus,
somewhat speculatively, lower prevalence of rs809682 T-allele
among less aggressive subjects in some studies may indirectly
suggest that this allele is promoting assertive behavior, and the
absence of it mitigates aggressive behavioral choices.
Two of the RBFOX1 variants were associated with alcohol
use disorder, rs8062784 in males and rs12921846 in females.
In both occasions, higher prevalence of alcohol use disorder
was present with the minor variant previously associated with
lower level aggression. Problematic alcohol use is often predictive
of violent behavior, but in this sample, the risk alleles were
not associated with aggressiveness. This result rather converges
with the personality findings in that in the risk allele carriers,
who constitute large majority of subjects, aggressiveness is
not common owing to the generally positive side of these
variants. According to this scenario, the RBFOX1 aggressiveness-
related variants owe this association to other coinciding genetic
or environmental factors. In the present sample, alcohol
use disorder was associated with both rs8062784 genotype
and neuroticism, and the genotype also with neuroticism.
A path analysis supported the possibility of mediation by
neuroticism between the genotype and alcohol use disorder.
Speculatively, the major rs8062784 allele, promoting lower
neuroticism and protective of alcohol use disorder in this
sample, may in general be associated with proactive behaviors
and thus become associated with anger in different types of
environment where the positive side of agonistic behavior cannot
be properly channeled.
Analysis simultaneously involving four gene polymorphisms
and many comparisons inflates the possibility of false positive
findings, and conventional correction for multiple testing would
render all associations non-significant. This is a major limitation
of the present longitudinal study, in that it is restricted in
its sample size. RBFOX1 has previously been associated with
aggression-related phenotypes in a number of GWAS. The
present sample is much smaller, but nevertheless, any large
direct effect of the genotype would have been detected. We do,
however, suggest a few potential mediatingmechanisms by which
the variants of the RBFOX1 gene may exert an indirect and
therefore small effect on aggression that becomes revealed in
large samples. The strengths of the study are its standard of data
collection performed in the uniform conditions of a laboratory,
the strong representation of the regional population, and the
solid rationale behind the selection of RBFOX1 as a target. Thus,
the findings that RBFOX1 variants appear to be associated with
personality traits and alcohol use disorder merit attention in
further studies.
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